Physiological and pharmacological differences exist between men and women. Women wake faster than men following general anaesthesia. Women also differ from men in their postoperative recovery as reflected by differences in postoperative pain, nausea and vomiting and overall quality of recovery. These gender differences seem to be more pronounced in premenopausal women, suggesting hormonal mechanisms are a major contributing factor.
HoldcroftA.Females and their variability. Anaesthesia1997; 52: 931–934.
2.
CicconeG.K., HoldcroftA.Drugs and sex differences: a review of drugs relating to anaesthesia. Br J Anaesth1999; 82: 255–265.
3.
KashubaA.D., NafzigerA.N.Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs. Clin Pharmacokinetic1998; 34: 203–218.
4.
KandoJ.C., YonkersK.A., ColeJ.O.Gender as a risk factor for adverse events to medications. Drugs1995; 50: 1–6.
5.
GanT.J., GlassP.S., SiglJ., SebelP., PayneF., RosowC.Women emerge from general anesthesia with propofol/alfen-tanil/nitrous oxide faster than men. Anesthesiology1999; 90: 1283–1287.
6.
MylesP.S., McLeodA.D., HuntJ.O., FletcherH.Sex differences in speed of emergence and quality of recovery after anaesthesia: cohort study. BMJ2001; 322: 710–711.
7.
ApfelbaumJ.L., GraselaT.H., HugC.C.Jr., McLeskeyC.H., NahrwoldM.L., RoizenM.F.The initial clinical experience of 1819 physicians in maintaining anesthesia with propofol: characteristics associated with prolonged time to awakening. Anesth Analg1993; 77: S10–14.
8.
HoymorkS.C., RaederJ., GrimsmoB., SteenP.A.Bispectral index, serum drug concentrations and emergence associated with individually adjusted target-controlled infusions of remifentanil and propofol for laparoscopic surgery. Br J Anaesth2003; 91: 773–780.
9.
BuchananF.F., MylesP.S., LeslieK., ForbesA., CicuttiniF.Gender and recovery after general anesthesia combined with neuromuscular blocking drugs. Anesth Analg2006; 102: 291–297.
10.
PleymH., SpigsetO., KharaschE.D., DaleO.Gender differences in drug effects: implications for anesthesiologists. Acta Anaesthesiol Scand2003; 47: 241–259.
11.
MollerD.H., GlassP.S.A.Should a patient's gender alter the anaesthetic plan?Curr Opin Anaesthesiol2003; 16: 379–383.
12.
ShawR.W.Neuroendocrinology of the menstrual cycle in humans. Clin Endocrinol Metab1978; 7: 531–559.
13.
PaeratakulS., AdairL.S., ZhaiF., GeK., PopkinB.M.Sex difference in measures of body fatness and the possible difference in the effect of dietary fat on body fatness in men and women. Eur J Clin Nutr1999; 53: 865–871.
14.
BuchholzA.C., RafiiM., PencharzP.B.Is resting metabolic rate different between men and women?Br J Nutr2001; 86: 641–646.
15.
StachenfeldN.S., TaylorH.S.Effects of estrogen and progesterone administration on extracellular fluid. J Appl Physiol2004; 96: 1011–1018.
16.
StachenfeldN.S., SilvaC., KeefeD.L., KokoszkaC.A., NadelE.R.Effects of oral contraceptives on body fluid regulation. J Appl Physiol1999; 87: 1016–1025.
17.
OlsonB.R., FormanM.R., LanzaE., McAdamP.A., BeecherG., KimzeyL.M.Relation between sodium balance and menstrual cycle symptoms in normal women. Ann Intern Med1996; 125: 564–567.
18.
LandauR.L., LugibihiK., BergenstalD.M., DimickD.F.The metabolic effects of progesterone in man: dose response relationships. J Lab Clin Med1957; 50: 613–620.
19.
LauerM.S., AndersonK.M., LarsonM.G., LevyD.A new method for indexing left ventricular mass for differences in body size. Am J Cardiol1994; 74: 487–491.
20.
de SimoneG., DevereuxR.B., MaggioniA.P., GoriniM., de DivitiisO., VerdecchiaP.Different normalizations for body size and population attributable risk of left ventricular hypertrophy: the MAVI study. Am J Hypertens2005; 18: 1288–1293.
21.
CainP.A., AhlR., HedstromE., UganderM., Allansdotter-JohnssonA., FribergP.Physiological determinants of the variation in left ventricular mass from early adolescence to late adulthood in healthy subjects. Clin Physiol Funct Imaging2005; 25: 332–339.
22.
GrandiA.M., VencoA., BarzizzaF., ScaliseF., PantaleoP., FinardiG.Influence of age and sex on left ventricular anatomy and function in normals. Cardiology1992; 81: 8–13.
23.
ChungA.K., DasS.R., LeonardD., PeshockR.M., KaziF., AbdullahS.M.Women have higher left ventricular ejection fractions than men independent of differences in left ventricular volume: the Dallas Heart Study. Circulation2006; 113: 1597–1604.
24.
LegatoM.J.Gender and the heart: sex-specific differences in normal anatomy and physiology. J Gend Specif Med2000; 3: 15–18.
25.
BurkeJ.H., GoldbergerJ.J., EhlertF.A., KruseJ.T., ParkerM.A., KadishA.H.Gender differences in heart rate before and after autonomic blockade: evidence against an intrinsic gender effect. Am J Med1996; 100: 537–543.
26.
WiinbergN., HøegholmA., ChristensenH.R., BangL.E., MikkelsenK.L., NielsenP.E.24-h ambulatory blood pressure in 352 normal Danish subjects, related to age and gender. Am J Hypertens1995; 8: 978–986.
27.
BurtV.L., CutlerJ.A., HigginsM., HoranM.J., LabartheD., WheltonP.Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension1995; 26: 60–69.
28.
ReckelhoffJ.F.Gender differences in the regulation of blood pressure. Hypertension2001; 37: 1199–1208.
29.
MendelsohnM.E., KarasR.H.The protective effects of estrogen on the cardiovascular system. N Engl J Med1999; 340: 1801–1811.
MeadJ.Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis1980; 121: 339–342.
32.
McClaranS.R., HarmsC.A., PegelowD.F., DempseyJ.A.Smaller lungs in women affect exercise hyperpnea. J Appl Physiol1998; 84: 1872–1881.
33.
HarmsC.A., McClaranS.R., NickeleG.A., PegelowD.F., NelsonW.B., DempseyJ.A.Exercise-induced arterial hypoxaemia in healthy young women. J Physiol1998; 507: 619–628.
34.
KilbrideE., McLoughlinP., GallagherC.G., HartyH.R.Do gender differences exist in the ventilatory response to progressive exercise in males and females of average fitness?Eur J Appl Physiol2003; 89: 595–602.
35.
MeadJ.Dysanapsis in normal lungs assessed by the relationship between maximal flow, static recoil, and vital capacity. Am Rev Respir Dis1980; 121: 339–342.
36.
ThurlbeckW.M.Postnatal human lung growth. Thorax1982; 37: 564–571.
37.
CharkoudianN., JoynerM.J.Physiologic considerations for exercise performance in women. Clin Chest Med2004; 25: 247–255.
38.
MorelliC., BadrM.S., MateikaJ.H.Ventilatory responses to carbon dioxide at low and high levels of oxygen are elevated after episodic hypoxia in men compared with women. J Appl Physiol2004; 97: 1673–1680.
39.
RegensteinerJ.G., PickettC.K., McCulloughR.E., WeilJ.V., MooreL.G.Possible gender differences in the effect of exercise on hypoxic ventilatory response. Respiration1988; 53: 158–165.
40.
JensenD., WolfeL.A., O'DonnellD.E., DaviesG.A.L.Chemoreflex control of breathing during wakefulness in healthy men and women. J Appl Physiol2005; 98: 822–828.
41.
BaylissD.A., MillhornD.E.Central neural mechanisms of progesterone action: application to the respiratory system. J Appl Physiol1992; 73: 393–404.
42.
SchoeneR.B., RobertsonH.T., PiersonD.J., PetersonA.P.Respiratory drives and exercise in menstrual cycles of athletic and nonathletic women. J Appl Physiol1981; 50: 1300–1305.
43.
PrestonR.J., HeenanA.P., WolfeL.A.Physicochemical analysis of phasic menstrual cycle effects on acid-base balance. Am J Physiol Regul Integr Comp Physiol2001; 280: R481–487.
44.
MillerJ.A., AnactaL.A., CattranD.C.Impact of gender on the renal response to angiotensin II. Kidney Int1999; 55: 278–285.
45.
WessonL.G.Renal hemodynamics in physiological states. In: The Physiology of the Human Kidney, New York, Grune and Stratton1969. p. 96–106.
46.
HarrisR.Z., BenetL.Z., SchwartzJ.B.Gender effects in pharmacokinetics and pharmacodynamics. Drugs1995; 50: 222–239.
47.
SlackT.K., WilsonD.M.Normal renal function: CIN and CPAH in healthy donors before and after nephrectomy. Mayo Clin Proc1976; 51: 296–300.
48.
Pechere-BertschiA., BurnierM.Female sex hormones, salt, and blood pressure regulation. Am J Hypertens2004; 17: 9941–001.
49.
DanserA.H., DerkxF.H., SchalekampM.A., HenseH.W., RieggerG.A., SchunkertH.Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens1998; 16: 853–862.
50.
FerraroR., LilliojaS., FontvieilleA.M., RisingR., BogardusC., RavussinE.Lower sedentary metabolic rate in women compared with men. J Clin Invest1992; 90: 780–784.
51.
BuchholzA.C., RafiiM., PencharzP.B.Is resting metabolic rate different between men and women?Br J Nutr2001; 86: 641–646.
52.
WebbP.24-hour energy expenditure and the menstrual cycle. Am J Clin Nutr1986; 44: 614–619.
GoldsteinJ.M., SeidmanL.J., HortonN.J., MakrisN., KennedyD.N., CavinessVSJr.Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cereb Cortex2001; 11: 490–497.
55.
RabinowiczT., DeanD.E., PetetotJ.M., de Courten-MyersG.M.Gender differences in the human cerebral cortex: more neurons in males; more processes in females. J Child Neurol1999; 14: 98–107.
56.
KawachiT., IshiiK., SakamotoS., MatsuiM., MoriT., SasakiM.Gender differences in cerebral glucose metabolism: a PET study. J Neurol Sci2002; 199: 79–83.
57.
CahillL., UncapherM., KilpatrickL., AlkireM.T., TurnerJ.Sex-related hemispheric lateralization of amygdala function in emotionally influenced memory: an FMRI investigation. Learn Mem2004; 11: 261–266.
58.
GandhiM., AweekaF., GreenblattR.M., BlaschkeT.F.Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol2004; 44: 499–523.
59.
HutsonW.R., RoehrkasseR.L., WaldA.Influence of gender and menopause on gastric emptying and motility. Gastroenterology1989; 96: 11–17.
SingerA.J., BrandtL.J.Pathophysiology of the gastrointestinal tract during pregnancy. Am J Gastroenterol1991; 86: 1695–1712.
62.
GillR.C., MurphyP.D., HooperH.R., BowesK.L., KingmaY.J.Effect of the menstrual cycle on gastric emptying. Digestion1987; 36: 168–174.
63.
HorowitzM., MaddernG.J., ChattertonB.E., CollinsP.J., PetruccoO.M., SeamarkR.The normal menstrual cycle has no effect on gastric emptying. Br J Obstet Gynaecol1985; 92: 743–746.
64.
ChenM-LConfounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation. Clin Pharmacol Ther2005; 78: 322–329.
65.
FrezzaM., di PadovaC., PozzatoG., TerpinM., BaraonaE., LieberC.S.High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med1990; 322: 95–99.
66.
JonesB.M., JonesM.K.Alcohol effects in women during the menstrual cycle. Ann N Y Acad Sci1976; 273: 576–587.
67.
LammersS.M., MainzerD.E., BretelerM.H.Do alcohol pharmacokinetics in women vary due to the menstrual cycle?Addiction1995; 90: 23–30.
68.
XueF.S., LiaoX., LiuJ.H., TongS.Y., ZhangY.M., ZhangR.J., AnG.Dose-response curve and time-course of effect of vecuronium in male and female patients. Br J Anaesth1998; 80: 720–724.
69.
XueF.S., AnG., LiaoX., ZouQ., LuoL.K.The pharmacokinetics of vecuronium in male and female patients. Anesth Analg1998; 86: 1322–1327.
70.
SempleP., HopeD.A., ClyburnP., RodbertA.Relative potency of vecuronium in male and female patients in Britain and Australia. Br J Anaesth1994; 72: 190–194.
71.
HoughtonI.T., AunC.S., OhT.E.Vecuronium: an anthropometric comparison. Anaesthesia1992; 47: 741–746.
72.
XueF.S., TongS.Y., LiaoX., LiuJ.H., AnG., LuoL.K.Dose-response and time course of effect of rocuronium in male and female anesthetized patients. Anesth Analg1997; 85: 667–671.
73.
DonatiF., BevanD.The influence of patient's sex, age and weight on pancuronium onset time. Can J Anaesth1986; 33: 586.
74.
ParkerC.J., HunterJ.M., SnowdonS.L.Effect of age, sex and anaesthetic technique on the pharmacokinetics of atracurium. Br J Anaesth1992; 69: 439–443.
OchsH.R., GreenblattD.J., DivollM., AbernethyD.R., FeyerabendH., DenglerH.J.Diazepam kinetics in relation to age and sex. Pharmacology1982; 23: 24–30.
77.
GreenblattD.J., AbernethyD.R., LocniskarA., HarmatzJ.S., LimjucoR.A., ShaderR.I.Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology1984; 61: 27–35.
78.
VuykJ., OostwouderC.J., VletterA.A., BurmA.G., BovillJ.G.Gender differences in the pharmacokinetics of propofol in elderly patients during and after continuous infusion. Br J Anaesth2001; 86: 183–188.
79.
ShaferA., DozeV.A., ShaferS.L., WhiteP.F.Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology1988; 69: 348–356.
80.
DaleO., HynneH., ParivarK., JohanssonE., WidmanM.Pharmacokinetics of eltanolone in male and female patients following intravenous bolus injection. Acta Anaesthesiol Scand1999; 43: 415–420.
81.
VerbeeckR.K., CardinalJ.A., WallaceS.M.Effect of age and sex on the plasma binding of acidic and basic drugs. Eur J Clin Pharmacol1984; 27: 91–97.
82.
TsenL.C., ArthurG.R., DattaS., HornsteinM.D., BaderA.M.Estrogen-induced changes in protein binding of bupivacaine during in vitro fertilization. Anesthesiology1997; 87: 879–883.
83.
WalleU.K., FaganT.C., TopmillerM.J., ConradiE.C., WalleT.The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers. Br J Clin Pharmacol1994; 37: 21–25.
84.
WoodM., WoodA.J.Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant. Clin Pharmacol Ther1981; 29: 522–526.
85.
SchmidtR., BaumannF., HanschmannH., GeisslerF., PreissR.Gender difference in ifosfamide metabolism by human liver microsomes. Eur J Drug Metab Pharmacokinet2001; 26: 193–200.
86.
HuntC.M., WesterkamW.R., StaveG.M.Effect of age and gender on the activity of human hepatic CYP3A. Biochem Pharmacol1992; 44: 275–283.
87.
SchmuckerD.L., WoodhouseK.W., WangR.K., WynneH., JamesO.F., McManusM.Effects of age and gender on in vitro properties of human liver microsomal monooxygenases. Clin Pharmacol Ther1990; 48: 365–374.
88.
ChiouW.L., JeongH.Y., WuT.C., MaC.Use of the erythromycin breath test for in vivo assessments of cytochrome P4503A activity and dosage individualization. Clin Pharmacol Ther2001; 70: 305–310.
89.
WatkinsP.B., TurgeonD.K., SaengerP., LownK.S., KolarsJ.C., HamiltonT.Comparison of urinary 6-beta-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity. Clin Pharmacol Ther1992; 52: 265–273.
90.
Krecic-ShepardM.E., BarnasC.R., SlimkoJ., JonesM.P., SchwartzJ.B.Gender-specific effects on verapamil pharmacokinetics and pharmacodynamics in humans. J Clin Pharmacol2000; 40: 219–230.
91.
ThummelK.E., ShenD.D., PodollT.D., KunzeK.L., TragerW.F., BacchiC.E.Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation. J Pharmacol Exp Ther1994; 271: 557–566.
92.
ThummelK.E., ShenD.D., PodollT.D., KunzeK.L., TragerW.F., BacchiC.E.Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation. J Pharmacol Exp Ther1994; 271: 557–566.
93.
NishiyamaT., MatsukawaT., HanaokaK.The effects of age and gender on the optimal premedication dose of intramuscular midazolam. Anesth Analg1998; 86: 1103–1108.
94.
KashubaA.D., BertinoJ.S.Jr., RocciM.L.Jr., KulawyR.W., BeckD.J., NafzigerA.N.Quantification of 3-month intraindividual variability and the influence of sex and menstrual cycle phase on CYP3A activity as measured by phenotyping with intravenous midazolam. Clin Pharmacol Ther1998; 64: 269–277.
95.
KinironsM.T., O'SheaD., KimR.B., GroopmanJ.D., ThummelK.E., WoodA.J.Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A. Clin Pharmacol Ther1999; 66: 224–231.
96.
GreenblattD.J., LocniskarA., ScavoneJ.M., BlydenG.T., OchsH.R., HarmatzJ.S.Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam. Anesth Analg1986; 65: 176–180.
97.
GorskiJ.C., JonesD.R., Haehner-DanielsB.D., HammanM.A., O'MaraE.M.Jr., HallS.D.The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin. Clin Pharmacol Ther1998; 64: 133–143.
98.
CumminsC.L., WuC-Y, BenetL.Z.Sex-related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P-glycoprotein. Clin Pharmacol Ther2002; 72: 474–489.
99.
SchuetzE.G., FuruyaK.N., SchuetzJ.D.Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther1995; 275: 1011–1018.
100.
SkettP.Biochemical basis of sex differences in drug metabolism. Pharmacol Ther1988; 38: 269–304.
101.
WadeliusM., DarjE., FrenneG., RaneA.Induction of CYP2D6 in pregnancy. Clin Pharmacol Ther1997; 62: 400–407.
102.
OramM., WilsonK., BurnettD.The influence of oral contraceptives on the metabolism of methaqualone in man. Br J Clin Pharmacol1982; 14: 341–345.
103.
BruguerolleB., ToumiM., FarajF., VervloetD., RazzoukH.Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics. Eur J Clin Pharmacol1990; 39: 59–61.
104.
LaneJ.D., SteegeJ.F., RuppS.L., KuhnC.M.Menstrual cycle effects on caffeine elimination in the human female. Eur J Clin Pharmacol1992; 43: 543–546.
KirkwoodC., MooreA., HayesP., DeVaneC L., PeloneroA.Influence of menstrual cycle and gender on alprazolam pharmacokinetics. Clin Pharmacol Ther1991; 50: 404–409.
107.
KharaschE.D., RussellM., GartonK., LentzG., BowdleT.A., CoxK.Assessment of cytochrome P450 3A4 activity during the menstrual cycle using alfentanil as a noninvasive probe. Anesthesiology1997; 87: 26–35.
108.
RubioA., CoxC.Sex, age and alfentanil pharmacokinetics. Clin Pharmacokinet1991; 21: 81–82.
109.
LemmensH.J., BurmA.G., HennisP.J., GladinesM.P., BovillJ.G.Influence of age on the pharmacokinetics of alfentanil. Gender dependence. Clin Pharmacokinet1990; 19: 416–422.
110.
ZeinerA.R., KeggP.S.Menstrual cycle and oral contraceptive effects on alcohol pharmacokinetics in caucasian females. Curr Alcohol1982; 8: 47–56.
111.
MacdonaldJ.I., HermanR.J., VerbeeckR.K.Sex-difference and the effects of smoking and oral contraceptive steroids on the kinetics of diflunisal. Eur J Clin Pharmacol1990; 38: 175–179.
112.
GreenblattD.J., DivollM., HarmatzJ.S., ShaderR.I.Oxazepam kinetics: effects of age and sex. J Pharmacol Exp Ther1980; 215: 86–91.
113.
DivollM., GreenblattD.J., HarmatzJ.S., ShaderR.I.Effect of age and gender on disposition of temazepam. J Pharm Sci1981; 70: 1104–1107.
114.
MinersJ.O., AttwoodJ., BirkettD.J.Influence of sex and oral contraceptive steroids on paracetamol metabolism. Br J Clin Pharmacol1983; 16: 503–509.
115.
WalleT., WalleU.K., CowartT.D., ConradiE.C.Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects. Clin Pharmacol Ther1989; 46: 257–263.
116.
SchniderT.W., MintoC.F., GambusP.L., AndresenC., GoodaleD.B., ShaferS.L.The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology1998; 88: 1170–1182.
117.
CerruttiJ.A., QuagliaN.B., BrandoniA., TorresA.M.Effects of gender on the pharmacokinetics of drugs secreted by the renal organic anions transport systems in the rat. Pharmacol Res2002; 45: 107–112.
118.
GaudryS.E., SitarD.S., SmythD.D., McKenzieJ.K., AokiF.Y.Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine. Clin Pharmacol Ther1993; 54: 23–27.
119.
PfaffD.W., McEwenB.S.Actions of estrogens and progestins on nerve cells. Science1983; 219: 808–814.
120.
McEwenB.S., AlvesS.E.Estrogen actions in the central nervous system. Endocr Rev1999; 20: 279–307.
121.
RupprechtR., ReulJ.M., TrappT., van SteenselB., WetzelC., DammK.Progesterone receptor-mediated effects of neuroactive steroids. Neuron1993; 11: 523–530.
122.
MajewskaM.D.Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol1992; 38: 379–395.
123.
ManberR., ArmitageR.Sex, steroids, and sleep: a review. Sleep1999; 22: 540–555.
124.
BitranD., PurdyR.H., KelloggC.K.Anxiolytic effect of progesterone is associated with increases in cortical allopregnanolone and GABAA receptor function. Pharmacol Biochem Behav1993; 45: 423–428.
125.
NadesonR., GoodchildC.S.Antinociceptive properties of neurosteroids III: experiments with alphadolone given intravenously, intraperitoneally, and intragastrically. Br J Anaesth2001; 86: 704–708.
MerrymanW., BoimanR., BarnesL., RothchildI.Progesterone anesthesia in human subjects. J Clin Endocrinol Metab1954; 14: 1567–1569.
128.
CarlP., HogskildeS., NielsenJ.W., SorensenM.B., LindholmM., KarlenB.Pregnanolone emulsion. A preliminary pharmacokinetic and pharmacodynamic study of a new intravenous anaesthetic agent. Anaesthesia1990; 45: 189–197.
129.
ErdenV., YanginZ., ErkalpK., DelatiogluH., BahceciF., SeyhanA.Increased progesterone production during the luteal phase of menstruation may decrease anesthetic requirement. Anesth Analg2005; 101: 1007–1111.
130.
GeeK.W., BolgerM.B., BrintonR.E., CoiriniH., McEwenB.S.Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J Pharmacol Exp Ther1988; 246: 803–812.
131.
HarrisonN.L., MajewskaM.D., HarringtonJ.W., BarkerJ.L.Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex. J Pharmacol Exp Ther1987; 241: 346–353.
132.
RudickC.N., WoolleyC.S.Estradiol induces a phasic Fos response in the hippocampal CA1 and CA3 regions of adult female rats. Hippocampus2000; 10: 274–283.
133.
WoolleyC.S., SchwartzkroinP.A.Hormonal effects on the brain. Epilepsia1998; 39(Suppl 8): S2–8.
AloisiA.M., BonifaziM.Sex hormones, central nervous system and pain. Horm Behav2006; 50: 1–7.
136.
MashourG.A.Integrating the science of consciousness and anesthesia. Anesth Analg2006; 103: 975–982.
137.
CampagnaJ.A., MillerK.W., FormanS.A.Mechanisms of actions of inhaled anesthetics. N Engl J Med2003; 348: 2110–2124.
138.
FranksN.P., LiebW.R.Molecular and cellular mechanisms of general anaesthesia. Nature1994; 367: 607–614.
139.
GreifR., LacinyS., MokhtaraniM., DoufasA.G., BakhshandehM., DorferL.Transcutaneous electrical stimulation of an auricular acupuncture point decreases anesthetic requirement. Anesthesiology2002; 96: 306–312.
140.
GotoT., NakataY., MoritaS.The minimum alveolar concentration of xenon in the elderly is sex-dependent. Anesthesiology2002; 97: 1129–1132.
141.
GinT., ChanM.T.Decreased minimum alveolar concentration of isoflurane in pregnant humans. Anesthesiology1994; 81: 829–832.
142.
ChanM.T., MainlandP., GinT.Minimum alveolar concentration of halothane and enflurane are decreased in early pregnancy. Anesthesiology1996; 85: 782–786.
143.
EgerEI2nd, LasterM.J., GregoryG.A., KatohT., SonnerJ.M.Women appear to have the same minimum alveolar concentration as men: a retrospective study. Anesthesiology2003; 99: 1059–1061.
144.
HoymorkS.C., RaederJ.Why do women wake up faster than men from propofol anaesthesia?Br J Anaesth2005; 95: 627–633.
145.
KodakaM., JohansenJ.W., SebelP.S.The influence of gender on loss of consciousness with sevoflurane or propofol. Anesth Analg2005; 101: 377–381.
146.
KreuerS., SchreiberJ.U., BruhnJ., WilhelmW.Impact of patient age on propofol consumption during propofol-remifentanil anaesthesia. Eur J Anaesthesiol2005; 22: 123–128.
147.
WilhelmW., BuchingerH., BiedlerA., AltmannS., LarsenR., KreuerS.[Influence of gender on propofol consumption and recovery times]. Anaesthesist2005; 54: 567–574.
148.
LeslieP., DroverD.R.Women patients require more propofol for general anaesthesia than men. Anesthesiology2001; 95: A481.
149.
GlassP.S., BloomM., KearseL., RosowC., SebelP., ManbergP.Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology1997; 86: 836–847.
150.
KodakaM., AsanoK., MiyaoH.The propofol Cp50 of women for loss of consciousness is higher than that of men. Anesthesiology2002; 96: A446.
151.
VuykJ., OostwouderC.J., VletterA.A., BurmA.G., BovillJ.G.Gender differences in the pharmacokinetics of propofol in elderly patients during and after continuous infusion. Br J Anaesth2001; 86: 183–188.
152.
DominoK.B., PosnerK.L., CaplanR.A., CheneyF.W.Awareness during anesthesia: a closed claims analysis. Anesthesiology1999; 90: 1053–1061.
153.
PavlinD.J., RappS.E., PolissarN.L., MalmgrenJ.A., KoerschgenM., KeyesH.Factors affecting discharge time in adult outpatients. Anesth Analg1998; 87: 816–826.
154.
MertesP.M., LaxenaireM-C, AllaF.Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology2003; 99: 536–545.
155.
TaenzerA.H., ClarkC., CurryC.S.Gender affects report of pain and function after arthroscopic anterior cruciate ligament reconstruction. Anesthesiology2000; 93: 670–675.
156.
HarmonD., O'ConnorP., GleasaO., GardinerJ.Menstrual cycle irregularity and the incidence of nausea and vomiting after laparoscopy. Anaesthesia2000; 55: 1164–1167.
157.
MylesP.S., HuntJ.O., MoloneyJ.T.Postoperative ‘minor’ complications. Comparison between men and women. Anaesthesia1997; 52: 300–306.
158.
EdwardsF.H., CareyJ.S., GroverF.L., BeroJ.W., HartzR.S.Impact of gender on coronary bypass operative mortality. Ann Thorac Surg1998; 66: 125–131.
159.
ButterworthJ., JamesR., PrielippR., CereseJ., LivingstonJ., BurnettD.Female gender associates with increased duration of intubation and length of stay after coronary artery surgery. CABG Clinical Benchmarking Database Participants. Anesthesiology2000; 92: 414–424.
160.
KochC.G., KhandwalaF., CywinskiJ.B., IshwaranH., EstafanousF.G., LoopF.D.Health-related quality of life after coronary artery bypass grafting: a gender analysis using the Duke Activity Status Index. J Thorac Cardiovasc Surg2004; 128: 284–295.
161.
QuintanaJ.M., ArosteguiI., OribeV., Lopez de TejadaI., BarriosB., GarayI.Influence of age and gender on quality-of-life outcomes after cholecystectomy. Qual Life Res2005; 14: 815–825.
162.
MylesP.S., WilliamsD.L., HendrataM., AndersonH., WeeksA.M.Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients. Br J Anaesth2000; 84: 6–10.
163.
BeattieW.S., LindbladT., BuckleyD.N., ForrestJ.B.The incidence of postoperative nausea and vomiting in women undergoing laparoscopy is influenced by the day of menstrual cycle. Can J Anaesth1991; 38: 298–302.
164.
FujiiY., TanakaH., ToyookaH.Granisetron reduces postoperative nausea and vomiting throughout menstrual cycle. Can J Anaesth1997; 44: 489–493.
